Systemic ritoximab immunotherapy in the management of primary ocular adoexal lymphoma: Slagle institution experience.

dc.contributor.author	Dogan, Oner
dc.contributor.author	Tuncer, Samuray
dc.contributor.author	Basaran, Gul
dc.contributor.author	Buyukbabani, Nesimi
dc.contributor.author	Basaran, Mert
dc.contributor.author	Tanyildiz, Burak
dc.date.accessioned	2021-03-04T07:36:09Z
dc.date.available	2021-03-04T07:36:09Z
dc.identifier.citation	Tuncer S., Basaran M., Tanyildiz B., Buyukbabani N., Basaran G., Dogan O., "Systemic ritoximab immunotherapy in the management of primary ocular adoexal lymphoma: Slagle institution experience.", 50th Annual Meeting of the American-Society-of-Clinical-Oncology, Illinois, Amerika Birleşik Devletleri, 30 Mayıs - 03 Haziran 2014, cilt.32
dc.identifier.other	vv_1032021
dc.identifier.other	av_5f233b59-d206-41df-a87c-df3ce977caf5
dc.identifier.uri	http://hdl.handle.net/20.500.12627/66480
dc.identifier.uri	https://doi.org/10.1200/jco.2014.32.15_suppl.e19503
dc.language.iso	eng
dc.subject	Dahili Tıp Bilimleri
dc.subject	İç Hastalıkları
dc.subject	Onkoloji
dc.subject	Tıp
dc.subject	Sağlık Bilimleri
dc.subject	Klinik Tıp (MED)
dc.subject	Klinik Tıp
dc.subject	ONKOLOJİ
dc.title	Systemic ritoximab immunotherapy in the management of primary ocular adoexal lymphoma: Slagle institution experience.
dc.type	Bildiri
dc.contributor.department	, ,
dc.identifier.volume	32
dc.contributor.firstauthorID	143999

Files in this item

Files	Size	Format	View
There are no files associated with this item.